Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM Pb Multiple | 0.6x - 0.7x | 0.7x |
| Historical Pb Multiple | 0.0x - 0.8x | 0.8x |
| Fair Value | ₩3,522 - ₩3,893 | ₩3,707 |
| Upside | -15.9% - -7.1% | -11.5% |
| Benchmarks | - | Full Ticker |
| Bolak Company Limited | - | KOSE:A002760 |
| Jeonjinbio Co., Ltd. | - | KOSDAQ:A110020 |
| NANOCMS Co.,Ltd | - | KOSDAQ:A247660 |
| Nano Chem Tech Inc. | - | KOSDAQ:A091970 |
| KOYJ Co., Ltd. | - | KOSDAQ:A121850 |
| Cell Bio Human Tech Co.,Ltd | - | KOSDAQ:A318160 |
| Select Price / Book Ratio | ||||||||
| Benchmark Companies | ||||||||
| A002760 | A110020 | A247660 | A091970 | A121850 | A318160 | |||
| KOSE:A002760 | KOSDAQ:A110020 | KOSDAQ:A247660 | KOSDAQ:A091970 | KOSDAQ:A121850 | KOSDAQ:A318160 | |||
| Historical Net Income Growth | ||||||||
| 5Y CAGR | -4.9% | NM- | NM- | NM- | NM- | NM- | ||
| 3Y CAGR | 29.6% | NM- | NM- | NM- | NM- | NM- | ||
| Latest Twelve Months | 56.4% | 167.5% | -113.9% | 18.3% | 40.2% | 335.8% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | 3.2% | -45.2% | -45.9% | -24.2% | -40.6% | 4.8% | ||
| Prior Fiscal Year | 6.3% | -41.1% | -90.2% | -10.7% | -27.1% | -6.8% | ||
| Latest Fiscal Year | 1.8% | 22.6% | -190.2% | -6.7% | -12.8% | 15.4% | ||
| Latest Twelve Months | 3.5% | 22.6% | -190.2% | -6.7% | -12.8% | 15.4% | ||
| Return on Equity | ||||||||
| 5 Year Average Margin | 3.1% | -39.9% | -14.9% | -22.5% | -56.9% | 3.2% | ||
| Prior Fiscal Year | 6.5% | -81.9% | -10.2% | -15.2% | -26.0% | -4.9% | ||
| Latest Twelve Months | 3.4% | 36.4% | -26.2% | -12.3% | -19.5% | 9.7% | ||
| Next Fiscal Year | 5.2% | -43.5% | #NUM! | -617.3% | #NUM! | 8.9% | ||
| Two Fiscal Years Forward | 5.0% | -68.1% | -24.1% | 150.1% | -34.1% | 8.8% | ||
| Current Trading Multiples | ||||||||
| Price / LTM Sales | 1.3x | 1.2x | 4.4x | 0.4x | 1.9x | 1.3x | ||
| Price / LTM EPS | 36.3x | 5.1x | -3.2x | -5.4x | -15.2x | 8.1x | ||
| Price / Book | 1.2x | 1.3x | 1.0x | 0.7x | 3.3x | 0.8x | ||
| Price / Fwd Book | 1.2x | 2.0x | 1.1x | -1.4x | 3.3x | 0.8x | ||
| Low | Mid | High | ||||||
| Benchmark P/B Ratio | 0.7x | 1.2x | 3.3x | |||||
| Historical P/B Ratio | 0.0x | 0.8x | 0.8x | |||||
| Selected P/B Multiple | 0.6x | 0.7x | 0.7x | |||||
| (x) Book Value | 45,965 | 45,965 | 45,965 | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | A002760 | A110020 | A247660 | A091970 | A121850 | A318160 | |
| Value of Common Equity | 61,038 | 22,239 | 21,869 | 19,913 | 40,389 | 35,533 | |
| (/) Shares Outstanding | 59.9 | 9.1 | 4.3 | 36.1 | 30.4 | 8.5 | |
| Implied Stock Price | 1,019.00 | 2,455.00 | 5,120.00 | 551.00 | 1,330.00 | 4,190.00 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 1,019.00 | 2,455.00 | 5,120.00 | 551.00 | 1,330.00 | 4,190.00 | |
| Trading Currency | KRW | KRW | KRW | KRW | KRW | KRW | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |